Wesley Buckingham
NanoString Technologies
23 Papers
111 Citations
Wesley Buckingham is an academic researcher from NanoString Technologies. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 8, co-authored 23 publications.
Chat about Author
Papers
PAM50 Risk of Recurrence Score Predicts 10-Year Distant Recurrence in a Comprehensive Danish Cohort of Postmenopausal Women Allocated to 5 Years of Endocrine Therapy for Hormone Receptor–Positive Early Breast Cancer
Anne Vibeke Lænkholm,Maj-Britt Jensen,Jens Ole Eriksen,Birgitte Bruun Rasmussen,Ann Knoop,Wesley Buckingham,Sean Ferree,Carl Schaper,Torsten O. Nielsen,Taryn Haffner,Torben Kibøl,Maj-Lis Møller Talman,Anne Marie Bak Jylling,Tomasz Piotr Tabor,Bent Ejlertsen +14 more
TL;DR: Prosigna ROR score improved the prediction of outcome in this nationwide Danish population and can reliably identify node-negative patients and a significant proportion of patients with one to three positive nodes who can be spared treatment with adjuvant chemotherapy.
149
Patent
Nanoparticle imaging system and method
William H. Cork,Timothy J. Patno,Mark Weber,Dave Morrow,Wesley Buckingham +4 more
- 02 Aug 2002
TL;DR: An apparatus and method for imaging metallic nanoparticles is provided in this paper, which includes a substrate holder for holding the substrate, a processor and memory device, an imaging module, illumination module, a power module, an input module, and an output module.
58
Population-based Study of Prosigna-PAM50 and Outcome Among Postmenopausal Women With Estrogen Receptor-positive and HER2-negative Operable Invasive Lobular or Ductal Breast Cancer.
Anne-Vibeke Lænkholm,Maj-Britt Jensen,Jens Ole Eriksen,Anne Roslind,Wesley Buckingham,Sean Ferree,Torsten O. Nielsen,Bent Ejlertsen +7 more
TL;DR: Prosigna PAM-50 provides significant prognostic information beyond the clinicopathologic factors in patients with invasive lobular breast cancer and could have an effect on the treatment decisions regarding the addition of chemotherapy for those in the intermediate ROR group.
23
Sensitive Assay for Identification of Methicillin-Resistant Staphylococcus aureus, Based on Direct Detection of Genomic DNA by Use of Gold Nanoparticle Probes
Ramesh Ramakrishnan,Wesley Buckingham,Marc Domanus,Linn Gieser,Karin Klein,Gregory T. Kunkel,Anna Prokhorova,Peter V. Riccelli +7 more
TL;DR: The ClearRead assay requires minimal amounts of genomic DNA and has been used to reliably identify MRSA from liquid cultures, based on the detection of the mecA and tuf genes.
Patent
Method for Detecting the Presence of a Target Analyte in a Test Spot
William H. Cork,Timothy J. Patno,Mark Weber,Dave Morrow,Wesley Buckingham +4 more
- 08 Sep 2006
TL;DR: An apparatus and method for imaging metallic nanoparticles is provided in this paper, which includes a substrate holder for holding the substrate, a processor and memory device, an imaging module, illumination module, a power module, an input module, and an output module.
8